(Q38440655)

English

Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium

scientific article published on 26 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

multiple sclerosis

0 references

object named as

Ilya Kister

1

0 references

4

object named as

Gary Cutter

0 references

2

object named as

Eric Chamot

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Joshua H Bacon

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Joseph Herbert

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

New York State Multiple Sclerosis Consortium

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

725-733

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Disability profile of MS did not change over 10 years in a population-based prevalence cohort

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Estimating direct effects in cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Rapid disease course in African Americans with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Will Rogers phenomenon in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Forward telescoping bias in reported age of onset: an example from cigarette smoking

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

The role of cancer registries in cancer control

1 reference

https://api.crossref.org/works/10.1177%2F1352458510396269

21 January 2018

Identifiers

10.1177/1352458510396269

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38440655&oldid=2063179412"